Taisho Pharmaceutical Holdings Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taisho Pharmaceutical Holdings Co Ltd with three other
companies in this sector in Japan:
Ono Pharmaceutical Co Ltd
sales of 244.80 billion Japanese Yen [US$2.18 billion]
of which 88%
was Products & Goods),
Ohki Healthcare Holdings Co Ltd
(222.34 billion Japanese Yen [US$1.98 billion]
Shionogi & Co Ltd
(338.89 billion Japanese Yen [US$3.02 billion]
of which 100%
During the year ended March of 2017, sales at
Taisho Pharmaceutical Holdings Co Ltd were ¥279.77 billion (US$2.49 billion).
decrease of 3.6%
versus 2016, when the company's sales were ¥290.14 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Taisho Pharmaceutical Holdings Co Ltd had sales
of ¥271.23 billion.
Contributing to the drop in overall sales was the 8.8% decline
in Medicine, from ¥109.41 billion to ¥99.78 billion.
There were also decreases in sales in
Self-Medication (down 0.4% to ¥179.99 billion)